Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomerase | 16 | 2016 | 44 | 3.610 |
Why?
|
| Telomere | 13 | 2021 | 56 | 3.340 |
Why?
|
| Longevity | 17 | 2023 | 147 | 2.540 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2016 | 84 | 1.350 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2022 | 767 | 1.230 |
Why?
|
| Germ Cells | 3 | 2016 | 73 | 1.100 |
Why?
|
| Aging | 6 | 2023 | 664 | 1.010 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 32 | 0.740 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 59 | 0.730 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 58 | 0.720 |
Why?
|
| Hypertension | 6 | 2023 | 796 | 0.700 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2010 | 49 | 0.680 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2010 | 43 | 0.590 |
Why?
|
| Stem Cells | 1 | 2016 | 141 | 0.490 |
Why?
|
| Genotype | 10 | 2023 | 730 | 0.490 |
Why?
|
| Dermatitis, Atopic | 2 | 2012 | 12 | 0.460 |
Why?
|
| Mice | 16 | 2023 | 5913 | 0.460 |
Why?
|
| Sapogenins | 1 | 2013 | 3 | 0.450 |
Why?
|
| Enzyme Activators | 1 | 2013 | 12 | 0.450 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 12 | 0.440 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 36 | 0.430 |
Why?
|
| Sirtuins | 3 | 2018 | 12 | 0.430 |
Why?
|
| Alleles | 6 | 2023 | 321 | 0.390 |
Why?
|
| Humans | 35 | 2023 | 37093 | 0.380 |
Why?
|
| Cell Differentiation | 3 | 2016 | 587 | 0.370 |
Why?
|
| Tacrolimus | 1 | 2010 | 10 | 0.360 |
Why?
|
| Aged, 80 and over | 13 | 2023 | 2379 | 0.360 |
Why?
|
| Animals | 19 | 2023 | 15081 | 0.350 |
Why?
|
| Lung | 1 | 2013 | 446 | 0.350 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 76 | 0.350 |
Why?
|
| DNA Damage | 2 | 2009 | 352 | 0.350 |
Why?
|
| RNA Interference | 1 | 2010 | 243 | 0.340 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 146 | 0.310 |
Why?
|
| Male | 23 | 2023 | 20025 | 0.300 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1015 | 0.300 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 578 | 0.300 |
Why?
|
| Chorionic Villi | 1 | 2006 | 4 | 0.280 |
Why?
|
| Spermatogenesis | 1 | 2008 | 155 | 0.280 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 905 | 0.260 |
Why?
|
| Japan | 7 | 2020 | 305 | 0.250 |
Why?
|
| Aged | 13 | 2023 | 6741 | 0.240 |
Why?
|
| Sirtuin 1 | 3 | 2016 | 32 | 0.240 |
Why?
|
| Phenylbutyrates | 1 | 2023 | 5 | 0.240 |
Why?
|
| Mice, Knockout | 5 | 2009 | 933 | 0.240 |
Why?
|
| Flavonols | 1 | 2023 | 16 | 0.230 |
Why?
|
| Brain | 3 | 2023 | 1346 | 0.230 |
Why?
|
| Hydrogen Sulfide | 1 | 2023 | 39 | 0.230 |
Why?
|
| Oxidative Stress | 1 | 2009 | 938 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 1609 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 190 | 0.210 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 78 | 0.200 |
Why?
|
| Receptors, Somatotropin | 1 | 2021 | 12 | 0.200 |
Why?
|
| Testis | 2 | 2016 | 187 | 0.200 |
Why?
|
| Heart Diseases | 1 | 2022 | 104 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2021 | 387 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 103 | 0.190 |
Why?
|
| Female | 14 | 2023 | 20969 | 0.180 |
Why?
|
| Antioxidants | 1 | 2023 | 416 | 0.180 |
Why?
|
| Leukocytes | 2 | 2018 | 72 | 0.180 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 357 | 0.180 |
Why?
|
| Coronary Disease | 1 | 2020 | 124 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2014 | 305 | 0.170 |
Why?
|
| Risk Factors | 7 | 2023 | 3562 | 0.170 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 142 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 18 | 0.150 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 18 | 0.150 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 245 | 0.150 |
Why?
|
| RNA | 2 | 2012 | 241 | 0.150 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 885 | 0.150 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1130 | 0.150 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 6 | 0.150 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 7 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2012 | 444 | 0.140 |
Why?
|
| Brain Ischemia | 1 | 2018 | 184 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2023 | 1378 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2009 | 326 | 0.140 |
Why?
|
| Ovum | 1 | 2016 | 35 | 0.140 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 333 | 0.130 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 61 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 189 | 0.130 |
Why?
|
| Encephalitis | 1 | 2016 | 42 | 0.130 |
Why?
|
| Ovary | 1 | 2016 | 108 | 0.130 |
Why?
|
| Cause of Death | 1 | 2016 | 156 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2003 | 539 | 0.130 |
Why?
|
| Transfection | 1 | 2016 | 523 | 0.130 |
Why?
|
| Blotting, Southern | 2 | 2006 | 69 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 145 | 0.120 |
Why?
|
| Neoplasms | 1 | 2005 | 1103 | 0.120 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 114 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 623 | 0.120 |
Why?
|
| Spermatozoa | 1 | 2016 | 200 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2006 | 617 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 22 | 0.120 |
Why?
|
| Monocytes | 1 | 2016 | 257 | 0.120 |
Why?
|
| Blotting, Western | 1 | 2016 | 859 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 81 | 0.110 |
Why?
|
| Bleomycin | 1 | 2013 | 20 | 0.110 |
Why?
|
| Base Sequence | 2 | 2017 | 997 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 643 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 43 | 0.110 |
Why?
|
| International Cooperation | 1 | 2012 | 46 | 0.110 |
Why?
|
| Xanthophylls | 2 | 2023 | 15 | 0.100 |
Why?
|
| Collagen | 1 | 2013 | 172 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 247 | 0.100 |
Why?
|
| Gestational Age | 2 | 2016 | 190 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2016 | 318 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 610 | 0.100 |
Why?
|
| Gene Frequency | 3 | 2018 | 195 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2013 | 272 | 0.100 |
Why?
|
| Heterozygote | 3 | 2018 | 93 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 204 | 0.100 |
Why?
|
| Phenotype | 3 | 2020 | 689 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 54 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 1371 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 173 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2021 | 13 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 75 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1039 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 143 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 628 | 0.090 |
Why?
|
| Treatment Outcome | 2 | 2012 | 1369 | 0.090 |
Why?
|
| Cell Line | 2 | 2010 | 1354 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 286 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 188 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2018 | 1908 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 515 | 0.080 |
Why?
|
| Inflammation | 1 | 2013 | 618 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2009 | 53 | 0.080 |
Why?
|
| Oogenesis | 1 | 2008 | 23 | 0.080 |
Why?
|
| Nicotine | 1 | 2010 | 257 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1198 | 0.080 |
Why?
|
| Multienzyme Complexes | 1 | 2008 | 69 | 0.080 |
Why?
|
| Haplotypes | 2 | 2018 | 182 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1568 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2012 | 681 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 28 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2006 | 150 | 0.070 |
Why?
|
| Cell Count | 1 | 2006 | 135 | 0.070 |
Why?
|
| Hawaii | 3 | 2020 | 1929 | 0.070 |
Why?
|
| Fetal Blood | 1 | 2006 | 50 | 0.070 |
Why?
|
| Graft Survival | 2 | 2003 | 39 | 0.070 |
Why?
|
| Time Factors | 2 | 2010 | 1742 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 1033 | 0.060 |
Why?
|
| Models, Biological | 1 | 2009 | 677 | 0.060 |
Why?
|
| Young Adult | 2 | 2018 | 4268 | 0.060 |
Why?
|
| Mutation | 1 | 2009 | 1095 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 286 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2006 | 435 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 626 | 0.060 |
Why?
|
| Meclizine | 1 | 2023 | 2 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 109 | 0.060 |
Why?
|
| Cell Survival | 2 | 2008 | 864 | 0.060 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 7 | 0.060 |
Why?
|
| Smoking | 1 | 2010 | 940 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2023 | 58 | 0.060 |
Why?
|
| Transgenes | 1 | 2003 | 59 | 0.060 |
Why?
|
| Asia | 1 | 2023 | 75 | 0.060 |
Why?
|
| DNA | 1 | 2006 | 574 | 0.060 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2002 | 5 | 0.060 |
Why?
|
| Adult | 3 | 2018 | 11712 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 2721 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.050 |
Why?
|
| DNA Replication | 1 | 2003 | 152 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 267 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 149 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 51 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 236 | 0.050 |
Why?
|
| Child | 1 | 2010 | 3131 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 129 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 313 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2021 | 130 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2021 | 325 | 0.050 |
Why?
|
| Incidence | 1 | 2023 | 922 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 674 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2021 | 353 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 19 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 85 | 0.040 |
Why?
|
| Independent Living | 1 | 2018 | 30 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 10129 | 0.040 |
Why?
|
| Cell Movement | 1 | 2002 | 571 | 0.040 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.040 |
Why?
|
| Survival Rate | 1 | 2018 | 311 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2017 | 517 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 898 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2017 | 55 | 0.040 |
Why?
|
| Laminin | 1 | 2017 | 61 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 11 | 0.040 |
Why?
|
| United States | 2 | 2017 | 4223 | 0.040 |
Why?
|
| Trophoblasts | 1 | 2016 | 24 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2021 | 854 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 75 | 0.040 |
Why?
|
| Genome, Human | 1 | 2017 | 135 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 48 | 0.030 |
Why?
|
| Placenta | 1 | 2016 | 97 | 0.030 |
Why?
|
| Chromatin | 1 | 2017 | 169 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1455 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 481 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 651 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 208 | 0.030 |
Why?
|
| Cognition | 1 | 2018 | 398 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 162 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 583 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 972 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 356 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 602 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 1492 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1207 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1549 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 4 | 0.020 |
Why?
|
| Bungarotoxins | 1 | 2010 | 21 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 15 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 9 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 77 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 90 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 199 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 224 | 0.020 |
Why?
|
| Saccharomycetales | 1 | 2009 | 7 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 106 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 316 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 481 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 58 | 0.020 |
Why?
|
| Food | 1 | 2008 | 100 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 230 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2002 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2002 | 14 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1398 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 54 | 0.010 |
Why?
|